Skip to main content
Log in

Formulation and evaluation of mucoadhesive glipizide microspheres

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this research was to formulate and system-atically evaluate in vitro and in vivo performances of mucoadhesive microspheres of glipizide. Glipizide microspheres containing chitosan were prepared by simple emulsification phase separation technique using glutaraldehyde as a cross-linking agent. Results of preliminary trials indicate that volume of cross-linking agent, time for cross-linking, polymer-to-drug ratio, and speed of rotation affected characteristics of microspheres. Microspheres were discrete, spherical, and free flowing. The microspheres exhibited good mucoadhesive property in the in vitro wash-off test and also showed a high percentage drug entrapment efficiency. A 32 full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X 1), and stirring speed (X 2) on dependent variables percentage mucoadhesion, t80, drug entrapment efficiency, and swelling index. The best batch exhibited a high drug entrapment efficiency of 75% and a swelling index of 1.42; percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained for more than 12 hours. The polymer-to-drug ratio had a more significant effect on the dependent variables. In vivo testing of the mucoadhesive microspheres to albino Wistar rats demonstrated significant hypoglycemic effect of glipizide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly (acryloyl hydroxymethyl starch) microsphere system for protein delivery.Pharm Res. 2001;18:1600–1606.

    Article  CAS  Google Scholar 

  2. Capan Y, Jiang G, Giovagnoli S, DeLuca PP. Preparation and characterization of poly (D,L-lactide-co-glycolide) microsphere for controlled release of human growth hormone.AAPS PharmSciTech. 2003;4:E28.

    Article  Google Scholar 

  3. Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design.J Control Release. 1998;51:115–122.

    Article  CAS  Google Scholar 

  4. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system.Int J Pharm. 2003;255:13–32.

    Article  CAS  Google Scholar 

  5. Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs.Chem Pharm Bull (Tokyo). 1992;40:2155–2158.

    CAS  Google Scholar 

  6. Nagai T, Nishimoto Y, Nambu N, Suzuki Y, Sekine K. Powder dosage form of insulin for nasal administration.J Control Release. 1984;1:15–22.

    Article  CAS  Google Scholar 

  7. Ilium L, Farraj NF, Critchley H, Davis SS. Nasal administration of gentamicin using a novel microsphere delivery system.Int J Pharm. 1988;46:261–265.

    Article  Google Scholar 

  8. Schaefer MJ, Singh J. Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.AAPS PharmSciTech. 2000;1:E32.

    Article  CAS  Google Scholar 

  9. Rao SB, Sharma CP. Use of chitosan as biomaterial: studies on its safety and hemostatic potential.J Biomed Mater Res. 1997;34:21–28.

    Article  CAS  Google Scholar 

  10. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers.Int J Pharm. 1992;78:43–48.

    Article  CAS  Google Scholar 

  11. Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study.Int J Pharm. 1996;145:231–240.

    Article  CAS  Google Scholar 

  12. Chowdary KPR, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note.AAPS PharmSciTech. 2003;4:E39.

    Article  CAS  Google Scholar 

  13. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.J Pharm Pharmacol. 1992;44:283–286.

    CAS  Google Scholar 

  14. Hari PR, Chandy T, Sharma CP. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.J Microencapsul. 1996;13:319–329.

    Article  CAS  Google Scholar 

  15. Liu LS, Liu SQ, Ng SY, Froix M, Heller J. Controlled release of interleukin 2 for tumour immunotherapy using alginate/chitosan porous microspheres.J Control Release. 1997;43:65–74.

    Article  CAS  Google Scholar 

  16. Patel JK, Bodar MS, Amin AF, Patel MM. Formulation and optimization of mucoadhesive microspheres of metoclopramide.Ind J Pharm Sci. 2004;66:300–305.

    CAS  Google Scholar 

  17. Dubey RR, Parikh RH. Two-stage optimization process for formulation of chitosan microspheres.AAPS PharmSciTech. 2004;5:E5.

    Article  Google Scholar 

  18. Foster RH, Plosker GL. Glipizide: a review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.Pharmacoeconomics. 2000;18:289–306.

    Article  CAS  Google Scholar 

  19. Thombre AG, Denoto AR, Gibbes DC. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients.J Control Release. 1999;60:333–341.

    Article  CAS  Google Scholar 

  20. Chowdary KPR, Balatripura G. Design and in vitro evaluation of mucoadhesive controlled release oral tablets of glipizide.Ind J Pharm Sci. 2003;65:591–594.

    CAS  Google Scholar 

  21. The United States Pharmacopeial Convention.The United States Pharmacopeia. XXVI. Rockville, MD: The United States Pharmacopeial Convention, Inc; 2003:859.

    Google Scholar 

  22. Eugene L. Milling. In: Lachman L, Liberman HA.The Theory and Practice of Industrial Pharmacy. 2nd ed. Mumbai, India: Varghese Publishing House; 1991:26–27.

    Google Scholar 

  23. The United States Pharmacopeial Convention.The United States Pharmacopeia. XXVI. Rockville, MD: The United States Pharmacopeial Convention, Inc; 2003:2528.

    Google Scholar 

  24. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres.Int J Pharm. 2002;249:7–21.

    Article  CAS  Google Scholar 

  25. Lehr CM, Bowstra JA, Tukker JJ, Junginger HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat.J Control Release. 1990;13:51–62.

    Article  CAS  Google Scholar 

  26. Nelson KG, Wang LY. Determination of time course of tablet disintegration II: method using continuous functions.J Pharm Sci. 1961;67:86–89.

    Article  Google Scholar 

  27. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation.J Pharm Sci. 2000;89:850–866.

    Article  CAS  Google Scholar 

  28. Bamba M, Puisieux F, Marty JP, Carstensen JT. Release mechanisms in gelforming sustained release preparations.Int J Pharm. 1979;2:307–315.

    Article  CAS  Google Scholar 

  29. Kahn CR, Shechter Y. Oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Theodore WR, Alan SN, Taylor P, Gilman AG, eds.Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: McGraw-Hill; 1991:1461–1495.

    Google Scholar 

  30. Berelowitz M, Fischette C, Cefelu W, Schade DS Sutfin T, Kourides IA. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM,Diabetes Care. 1994;17:1460–1464.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jayvadan K. Patel.

Additional information

Published: September 20, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, J.K., Patel, R.P., Amin, A.F. et al. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech 6, 10 (2005). https://doi.org/10.1208/pt060110

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060110

Keywords

Navigation